Rallybio Income Statement (2023-2025) | RLYB

Income Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.30M0.30M0.00M0.21M0.21M0.21M
Operating items
Research & Development 11.20M13.13M13.29M15.92M12.94M12.95M8.24M7.38M5.72M6.07M4.14M
Selling, General & Administrative 7.17M6.95M6.08M5.19M6.85M4.39M4.12M4.26M4.16M4.20M2.99M
Operating Expenses 18.37M20.08M19.36M21.11M19.79M17.33M12.37M11.65M9.88M10.27M7.14M
Operating Income -18.37M-20.08M-19.36M-21.11M-19.79M-17.04M-12.07M-11.61M-9.67M-10.06M-6.92M
EBIT -18.37M-20.08M-19.36M-21.11M-19.79M-17.04M-12.07M-11.61M-9.67M-10.06M-6.92M
Non-operating items
Non Operating Investment Income 0.15M-0.21M0.06M0.22M-0.09M0.24M-0.10M-0.02M-0.03M0.01M
Interest & Investment Income 1.55M1.61M1.54M1.45M1.28M1.14M0.99M0.81M0.64M0.52M0.46M
Other Non Operating Income 0.07M0.06M0.09M0.04M0.17M0.14M0.25M0.18M0.17M0.12M22.48M
Non Operating Income 1.62M1.67M1.64M1.48M1.44M1.29M1.24M0.99M0.82M0.64M22.94M
Net income details
EBT -16.75M-18.41M-17.73M-19.63M-18.34M-15.75M-10.83M-10.61M-8.85M-9.42M16.02M
Profit After Tax -17.32M-18.63M-18.37M-20.28M-19.03M-16.24M-11.47M-11.07M-9.44M-9.70M16.02M
Equity Income -0.56M-0.22M-0.65M-0.61M-0.69M-0.49M-0.64M-0.43M-0.59M-0.29M
Income from Continuing Operations -16.75M-18.41M-17.73M-19.63M-18.34M-15.75M-10.83M-10.61M-8.85M-9.42M16.02M
Consolidated Net Income -16.75M-18.41M-17.73M-19.63M-18.34M-15.75M-10.83M-10.61M-8.85M-9.42M16.02M
Income towards Parent Company -16.75M-18.41M-17.73M-19.63M-18.34M-15.75M-10.83M-10.61M-8.85M-9.42M16.02M
Net Income towards Common Stockholders -16.75M-18.41M-17.73M-19.63M-18.34M-15.75M-10.83M-10.61M-8.85M-9.42M16.02M
Additional items
EPS (Basic) -0.43-0.46-0.45-0.49-0.47-0.37-0.26-0.24-0.21-0.220.36
EPS (Weighted Average and Diluted) -0.43-0.46-0.45-0.49-0.47-0.37-0.26-0.24-0.21-0.220.36
Shares Outstanding (Weighted Average) 40.25M40.36M40.53M40.45M40.77M44.13M44.59M43.54M44.77M44.84M45.06M
Shares Outstanding (Diluted Average) 40.25M40.36M40.53M40.45M40.77M44.13M44.59M43.54M44.77M44.84M45.06M
EBITDA -17.16M-18.84M-18.31M-20.02M-19.11M-16.24M-11.23M-11.14M-9.46M-9.73M16.02M
Shares Outstanding 37.75M37.79M37.80M37.83M37.81M41.51M